Published:
May 13, 2021
Last Updated:
May 13, 2021
Services:
Chemicals More...
Priorities:
Achieving Sustainability More...
Topics:
Activities:
Other financial
Further Reading
Velo3D plans to go public in second half of 2021 via SPAC acquisition, aiming at $1.6 billion valuation
News Commentary | April 14, 2021
Velo3D has made strong progress in new product launch and business development in the past 12 months. It joins a surge of 3D printing startups going public through merging with a special purpose acquisition company (SPAC), alongside Desktop Metal, Markforged, and Rocket Lab. SPACs may make corporate... Not part of subscription
Solidia raises $78 million and names new CEO – will these developments finally lead to commercialization?
News Commentary | May 06, 2021
Solidia Technologies has a new CEO, Bryan Kalbfleisch, along with $78 million more in funding from Imperative Ventures, Zero Carbon Partners, and Breakthrough Energy Ventures, along with existing investors. The company has a promising technology, but the lack of scale‑up and commercialization ... Not part of subscription
G2 Venture closes $500 million fund targeting climate change-mitigating technologies but still lacks deep decarbonization startups
News Commentary | July 08, 2021
Last month, G2V announced the close of a $500 million fund following its inaugural $350 million fund in 2017. Continuing with its original investment thesis, G2V will target companies active in the energy, manufacturing, logistics, transportation, and agriculture industries, with an emphasis on "... Not part of subscription
by Kristin Marshall and Harini Venkataraman
Backed by Harry Sloan and Jeff Sagansky, this merger with Soaring Eagle Acquisition will give Ginkgo a pre-money equity valuation of $15 billion, with an additional $2.5 billion for the combined entity – one of the biggest SPAC deals in recent times. This news comes on the heels of Zymergen's IPO announcement, through which it raised $500 million. While the two have significantly evolved over the years, in Ginkgo's case, the company has further diversified through different spinouts targeting ag biologicals, alternative protein ingredients, and bioremediation. Clients should note that Ginkgo is playing a numbers game – it does not depend on any one project to succeed. Additional funding will only expand its reach and disruption potential.
For the original news article, click here .